10.63
price up icon0.28%   0.03
after-market アフターアワーズ: 10.67 0.04 +0.38%
loading

Novavax Inc (NVAX) 最新ニュース

pulisher
12:44 PM

(NVAX) Volatility Zones as Tactical Triggers - Stock Traders Daily

12:44 PM
pulisher
Sep 25, 2026

NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits

Sep 25, 2026
pulisher
Sep 24, 2026

Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - stocktwits.com

Sep 24, 2026
pulisher
Sep 24, 2026

Enterprise value to EBIT forward of Novavax, Inc. – BX:NVV1 - TradingView

Sep 24, 2026
pulisher
Sep 24, 2026

Novavax stock falls 2.59 percent below its yearly high - ad-hoc-news.de

Sep 24, 2026
pulisher
Sep 23, 2026

Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Sep 23, 2026
pulisher
Sep 23, 2026

Novavax stock falls 2.54 percent below its yearly high - AD HOC NEWS

Sep 23, 2026
pulisher
Sep 23, 2026

Novavax Inc (NVAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Sep 23, 2026
pulisher
Sep 23, 2026

Novavax Inc. Stock Rises 4.0%, Outperforms Peers - webull.com

Sep 23, 2026
pulisher
Sep 22, 2026

Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026
pulisher
Sep 22, 2026

Novavax, Inc. (NVAX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 22, 2026
pulisher
Sep 22, 2026

Novavax, Inc. (NVV1.F) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 22, 2026
pulisher
Sep 21, 2026

Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits

Sep 21, 2026
pulisher
Sep 20, 2026

Novavax stock gains as Q2 2026 revenue rises and vaccine focus deepens - AD HOC NEWS

Sep 20, 2026
pulisher
Sep 19, 2026

Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits

Sep 19, 2026
pulisher
Sep 18, 2026

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance

Sep 18, 2026
pulisher
Sep 18, 2026

Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Sep 18, 2026
pulisher
Sep 16, 2026

Do Novavax’s (NVAX) New Partnerships Offset Policy Risks From The Protecting Approved Care Act? - Yahoo Finance

Sep 16, 2026
pulisher
Sep 15, 2026

Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance

Sep 15, 2026
pulisher
Sep 15, 2026

Novavax Inc. stock underperforms Tuesday when compared to competitors - marketwatch.com

Sep 15, 2026
pulisher
Sep 15, 2026

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - finance.yahoo.com

Sep 15, 2026
pulisher
Sep 12, 2026

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance

Sep 12, 2026
pulisher
Sep 11, 2026

Novavax (NVAX) Laps the Stock Market: Here's Why - Yahoo Finance

Sep 11, 2026
pulisher
Sep 11, 2026

ETFs Investing in Novavax, Inc. Stocks - TradingView

Sep 11, 2026
pulisher
Sep 11, 2026

Novavax Inc Lobbyists, 2020 - opensecrets.org

Sep 11, 2026
pulisher
Sep 10, 2026

Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 10, 2026
pulisher
Sep 10, 2026

Novavax Highlights Sanofi, Pfizer Catalysts in Matrix-M Platform Pivot - TradingView

Sep 10, 2026
pulisher
Sep 10, 2026

Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10:00 AM - marketscreener.com

Sep 10, 2026
pulisher
Sep 10, 2026

Novavax at Citi summit: partnerships extend cash runway By Investing.com - Investing.com India

Sep 10, 2026
pulisher
Sep 10, 2026

Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor Conference - Yahoo Finance

Sep 10, 2026
pulisher
Sep 09, 2026

Novavax at cantor healthcare conference: pivot to licensing gains steam - investing.com

Sep 09, 2026
pulisher
Sep 09, 2026

Novavax at cantor healthcare conference: pivot to licensing gains steam By Investing.com - Investing.com Canada

Sep 09, 2026
pulisher
Sep 09, 2026

NVAX: Strategic shift to licensing and Matrix-M partnerships drives growth in vaccines and oncology - TradingView

Sep 09, 2026
pulisher
Sep 09, 2026

NVAX: Major pharma partnerships, Matrix-M expansion, and global commercialization drive future growth - TradingView

Sep 09, 2026
pulisher
Sep 09, 2026

GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits

Sep 09, 2026
$117.83
price down icon 3.06%
$35.80
price down icon 0.91%
$58.21
price down icon 0.14%
$255.96
price up icon 2.55%
ONC ONC
$360.85
price up icon 0.24%
$204.97
price up icon 2.56%
大文字化:     |  ボリューム (24 時間):